Scribe Therapeutics (SCTX) Stock
Industry: Biological Products, Except Diagnostic Substances · see every company filed here →
Sources Company filings, market prices and computed by Tenet Filings, prices and TenetHow we compute thisNot investment advice
Scribe Therapeutics, Inc. isn't scored yet Not enough ingested fundamentals to compute a Tenet Score for this stock.
Tenet Score
Not scored. We do not hold normalized financials for this listing, so the Tenet value screens do not apply. That is usually a foreign-domiciled ADR or a very new listing. Its price, chart, and news below are its own.
Price
Loading chart…
P/E
—
no P/E on file
P/B
—
no P/B on file
P/S
—
no P/S on file
ROE
—
no ROE for this year, and Tenet does not compute one yet
Operating margin
—
no operating margin on file
Net margin
—
no net margin on file
Current ratio
—
no current ratio on file
Net debt / EBITDA
—
no leverage ratio on file
EPS CAGR 5y
—
needs five years of positive earnings
Market cap
$237.2M
small cap
Div yield
—
no yield on file
52-wk range
13.50 – 39.60
low → high, since listing
Market cap: share price × the latest quarter's diluted weighted-average share count (vendor).
The rest of this report
Which sections of this report have data for this listing, and a live peek at each.
About Scribe Therapeutics, Inc.
We are a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to extend healthy lifespan through disease prevention and durable therapeutic intervention. While current genetic medicines are largely limited to r…
Not investment advice.




